Compare NRP & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRP | PAHC |
|---|---|---|
| Founded | 2002 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2002 | 2014 |
| Metric | NRP | PAHC |
|---|---|---|
| Price | $119.49 | $52.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $34.33 |
| AVG Volume (30 Days) | 35.0K | ★ 207.6K |
| Earning Date | 06-01-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.51% | 0.93% |
| EPS Growth | N/A | ★ 1883.33 |
| EPS | N/A | ★ 1.32 |
| Revenue | $216,119,000.00 | ★ $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ $11.28 | $39.38 |
| Revenue Growth | ★ 54.66 | 4.12 |
| 52 Week Low | $86.83 | $16.16 |
| 52 Week High | $128.60 | $56.30 |
| Indicator | NRP | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.12 | 59.27 |
| Support Level | $100.83 | $37.09 |
| Resistance Level | $123.40 | $56.14 |
| Average True Range (ATR) | 4.12 | 2.20 |
| MACD | -0.74 | -0.38 |
| Stochastic Oscillator | 38.53 | 65.74 |
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.